In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Mylan Inc.
The autoinjector will be free for insured patients and those whose annual income is less than $100,000.
Sangamo Therapeutics, Impax Laboratories and Portola Pharmaceutical are among the premarket movers in biotech.
The drug maker's shares have fallen 6.2% since Wednesday's market open.
The stock has taken a beating, but users of Afrezza are loyal to the drug.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.